Nanoarchitecting intelligently encapsulated designs for improved cancer therapy DOI Creative Commons

Ying‐Tong Ye,

Hong‐Ying Xia,

Jie Li

et al.

Frontiers in Bioengineering and Biotechnology, Journal Year: 2025, Volume and Issue: 13

Published: May 1, 2025

Despite the success in exploring various aspects of origination and therapeutic strategies, cancer has remained one most dreadful metabolic disorders due to failure eradicate tumors comprehensively frequent recurrence because acquired resistance drugs. Recently, several advancements have been evidenced fabrication smart nanocarriers encapsulated with multiple components. Several reasons for nanoencapsulation include enhancement bioavailability drugs, precise targetability reduce adverse effects on normal cells, ability enable controlled drug release rates at tumor sites. In addition, these protect cargo from deactivation, responsively delivering it based physiological or pathological characteristics tumors. this review, we present approaches therapy, including organic materials, inorganic components, their composites, as well biomembrane-based strategies. These along practical applications potential treatment, are discussed depth, highlighting advantages disadvantages, aiming reveal ultimate prospects enhancing delivery efficiency targeted therapy.

Language: Английский

Demystifying the potential of lipid-based nanocarriers in targeting brain malignancies DOI
Burcu Mesut,

Mazen Al-Mohaya,

Amol D. Gholap

et al.

Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2024, Volume and Issue: 397(12), P. 9243 - 9279

Published: July 4, 2024

Language: Английский

Citations

8

Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles DOI Creative Commons

Prieložná Jarmila,

Veronika Mikušová, Peter Mikuš

et al.

International Journal of Pharmaceutics X, Journal Year: 2024, Volume and Issue: 8, P. 100281 - 100281

Published: Aug. 28, 2024

Cancer is the leading cause of death globally, and conventional treatments have limited efficacy with severe side effects. The use nanotechnology has potential to reduce effects drugs by creating efficient controlled anticancer drug delivery systems. Nanoparticles (NPs) used as carriers offer several advantages, including enhanced protection, biodistribution, selectivity and, pharmacokinetics. Therefore, this review devoted various organic (lipid, polymeric) well inorganic nanoparticles based on different building units providing a wide range potent Within these nanoparticulate systems, chitosan (CS)-based NPs are discussed particular emphasis due unique properties CS its derivatives non-toxicity, biodegradability, mucoadhesivity, tunable physico-chemical biological allowing their alteration specifically target cancer cells. In context streamlining systems (DDS), innovative nanoplatform-based therapy pathways involving passive active targeting stimuli-responsive DDS enhancing overall orthogonality developed NP-DDS towards included. most up-to-date information delivering anti-cancer using modern dosage forms specifically, CSNPs, summarised evaluated concerning benefits, limitations, advanced applications.

Language: Английский

Citations

7

Comparison of passive targeted delivery of inorganic and organic nanocarriers among different types of tumors DOI
Alisa S. Postovalova,

Yulia A. Tishchenko,

Maria S. Istomina

et al.

Nanomedicine Nanotechnology Biology and Medicine, Journal Year: 2024, Volume and Issue: 59, P. 102753 - 102753

Published: May 9, 2024

Language: Английский

Citations

6

Navigating the future of cancer management through carbon nanodots: A review DOI

Arprita Malhan,

Mridul Guleria,

Ushasi Das

et al.

Nano-Structures & Nano-Objects, Journal Year: 2024, Volume and Issue: 39, P. 101217 - 101217

Published: June 17, 2024

Language: Английский

Citations

6

Research Progress of Polysaccharide-Gold Nanocomplexes in Drug Delivery DOI Creative Commons
Ming Song,

Adila Aipire,

Elzira Dilxat

et al.

Pharmaceutics, Journal Year: 2024, Volume and Issue: 16(1), P. 88 - 88

Published: Jan. 9, 2024

Clinical drug administration aims to deliver drugs efficiently and safely target tissues, organs, cells, with the objective of enabling their therapeutic effects. Currently, main approach enhance a drug’s effectiveness is ensuring its efficient delivery intended site. Due fact that there are still various drawbacks traditional methods, such as high toxicity side effects, insufficient specificity, poor targeting, pharmacokinetic performance, nanocarriers have emerged promising alternative. Nanocarriers possess significant advantages in due size tunability surface modifiability. Moreover, nano-drug systems demonstrated strong potential terms prolonging circulation time, improving bioavailability, increasing retention at tumor site, decreasing resistance, well reducing undesirable effects anticancer drugs. Numerous studies focused on utilizing polysaccharides nanodelivery carriers, developing based polysaccharides, or exploiting tumor-targeting ligands precision nanoparticle delivery. These types investigations become commonplace academic literature. This review elucidate preparation methods principles polysaccharide gold nanocarriers. It also provides an overview factors affect loading different kinds Additionally, it outlines strategies employed by improve efficiency The provide reference for further development research systems.

Language: Английский

Citations

5

Constructing Tumor Organoid-like Tissue for Reliable Drug Screening Using Liver-Decellularized Extracellular Matrix Scaffolds DOI Creative Commons
Zhoujiang Chen,

Lianlin Long,

Ji Wang

et al.

ACS Omega, Journal Year: 2024, Volume and Issue: unknown

Published: Jan. 29, 2024

The interplay between cells and their microenvironments plays a pivotal role in

Language: Английский

Citations

5

The Application of Selenium Nanoparticles in Immunotherapy DOI Creative Commons
Yu Yang, Ying Liu, Qingxia Yang

et al.

Nano Biomedicine and Engineering, Journal Year: 2024, Volume and Issue: 16(3), P. 345 - 356

Published: Sept. 1, 2024

Language: Английский

Citations

5

An insight on nanofibers assisted localized delivery of anti-cancer drugs to breast for an effective breast cancer treatment DOI
Shashank Chaturvedi, Vaibhav Rastogi, M. Aravind Kumar

et al.

Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 93, P. 105447 - 105447

Published: Feb. 2, 2024

Language: Английский

Citations

4

Enhanced Tumor Site Accumulation and Therapeutic Efficacy of Extracellular Matrix‐Drug Conjugates Targeting Tumor Cells DOI
Zhoujiang Chen,

Lianlin Long,

Ji Wang

et al.

Small, Journal Year: 2024, Volume and Issue: unknown

Published: June 3, 2024

Abstract The extracellular matrix (ECM) engages in regulatory interactions with cell surface receptors through its constituent proteins and polysaccharides. Therefore, nano‐sized conjugated doxorubicin (DOX) is utilized to produce matrix‐drug conjugates (ECM‐DOX) tailored for targeted delivery cancer cells. ECM‐DOX nanoparticles exhibit rod‐like morphology, boasting a commendable drug loading capacity of 4.58%, coupled acid‐sensitive release characteristics. Notably, enhance the uptake by tumor cells possess ability penetrate endothelial infiltrate multicellular spheroids. Mechanistic insights reveal that internalization nanoparticle facilitated clathrin‐mediated endocytosis macropinocytosis, intricately involving hyaluronic acid integrins. Pharmacokinetic assessments unveil prolonged blood half‐life at 3.65 h, substantial improvement over 1.09 h observed free DOX. A sustained accumulation effect sites, levels tissues surpassing those DOX several‐fold. profound therapeutic impact evident their notable inhibition growth, extension median survival time animals, significant reduction DOX‐induced cardiotoxicity. ECM platform emerges as promising carrier avant‐garde nanomedicines realm treatment.

Language: Английский

Citations

4

A Multifunctional Biomimetic Nanoplatform for Dual Tumor Targeting-Assisted Multimodal Therapy of Colon Cancer DOI
Xin Wan, Ying Zhang, Yiqun Wan

et al.

ACS Nano, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 19, 2024

The biomimetic nanoparticles (NPs) possessing abilities of tumor targeting and multimodal therapy show great potential for efficient combat colon cancer. Herein, we developed a multifunctional nanoplatform (Fe

Language: Английский

Citations

4